Find out What Are the Major Factors Behind the Synthetic Biology Market to Boom at Global Industry

ReportsnReports always aims at offering their clients an in-depth analysis and the best research material of the various market. This report on the global Synthetic Biology Market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts team.

Get Free Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=318512

The Synthetic Biology Market is expected to reach US$ 8.84 Billion by 2022 from an estimated US$ 3.57 Billion in 2017, at a CAGR of 19.9%. This report spread across 214 pages, profiling 12 companies and supported with 162 tables and 32 figures is now available in this research.

“The chassis organisms segment is expected to grow at the highest rate during the forecast period (2017-2022).”
On the basis of tools, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. The chassis organisms segment is expected to witness the highest growth during the forecast period due to the increasing research on chassis organisms and the rising global demand of for alternatives to fossil fuel.

“The gene synthesis technology is expected to hold the largest share of the market in 2017”
Based on technology, the synthetic biology market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, micro fluidics, and nanotechnology. The gene synthesis segment is expected to account for the largest share of the synthetic biology market. This is attributed to the factors such as growth in the energy and agriculture industry; applications in environmental testing; and research in DNA-based vaccines and bioengineered antibodies.

Avail Discount @ https://www.reportsnreports.com/contacts/discount.aspx?name=318512 .

“Pharmaceutical applications are expected to hold the largest share of the synthetic biology market in 2017.”
Based on application, the synthetic biology market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), environmental (bioremediation and biosensing), and food & agriculture applications. The pharmaceuticals sub segment is expected to account for the largest share in the market in 2017.

“China to witness the highest growth during the forecast period”
While the US is expected to hold the largest share of the global synthetic biology market in 2017, China is expected to witness the highest growth during 2017 to 2022. Rising R&D funding and awareness programs regarding synthetic biology are contributing to the growth of synthetic biology market in China.

Breakdown of primary participants’ profile:
• By Company Type – Tier 1–28%, Tier 2–33% and Tier 3–39%
• By Designation – C-level–42%, Director Level–33%, Others–25%
• By Region – North America–41%, Europe–35%, Asia Pacific–14%, RoW–10%

Report Highlights:
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

• To analyze strategic approaches such as collaborations, partnerships, and agreements; expansions; product launches; acquisitions; and other developments in the market

• To define, describe, and forecast the global market by tools, technologies, applications, and region

• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)

• To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

• To describe and forecast the market in terms of value, by region–Asia Pacific (APAC), Europe, North America, and Rest of the World (RoW) along with their respective countries

• To strategically profile key players and comprehensively analyze their core competencies in terms of key market developments, product portfolios, and financials

Competitive Landscape of Synthetic Biology Market:
1 Overview
2 Market Share Analysis, 2016
3 Competitive Scenario
3.1 Collaborations, Partnerships, and Agreements
3.2 Expansions
3.3 Product Launches
3.4 Acquisitions
3.5 Other Developments

Target Audience for Synthetic Biology Market: Pharmaceutical & drug manufacturers, Biotech companies, Enzyme & cosmetic manufacturers, Chemical & biofuel industries, Food & agriculture industries, Academic and government research institutes, Contract manufacturing organizations (CMOs) and contract research organizations (CROs), Venture capitalists and investors.

Top Key Players profiled in the Synthetic Biology Market include are Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US). Some other players in this market include Intrexon Corporation (US), Agilent Technologies (US), Amyris (US), Genescript Biotech Corporation (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US).

Access full report @ https://www.reportsnreports.com/purchase.aspx?name=318512 .

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India

About Us:-
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.